Urgent Need: Addressing Triple-Negative Breast Cancer Treatment Gaps for Black Women

Triple-negative breast cancer (TNBC) significantly impacts Black women in the U.S., leading to elevated mortality rates. A JAMA Network Open study highlights racial disparities in immunotherapy use. Effective treatments, like immune checkpoint inhibitors, must be accessible to all, particularly for Black patients, to improve survival rates and outcomes in TNBC.